LPL Financial LLC Has $950,000 Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

LPL Financial LLC trimmed its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 9.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,306 shares of the medical instruments supplier’s stock after selling 1,061 shares during the period. LPL Financial LLC’s holdings in LeMaitre Vascular were worth $950,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. KLP Kapitalforvaltning AS acquired a new stake in LeMaitre Vascular in the fourth quarter valued at $811,000. Sei Investments Co. increased its position in LeMaitre Vascular by 9.6% during the fourth quarter. Sei Investments Co. now owns 96,857 shares of the medical instruments supplier’s stock worth $8,924,000 after buying an additional 8,494 shares during the last quarter. Teacher Retirement System of Texas lifted its position in shares of LeMaitre Vascular by 31.8% in the fourth quarter. Teacher Retirement System of Texas now owns 101,851 shares of the medical instruments supplier’s stock valued at $9,385,000 after buying an additional 24,586 shares during the last quarter. Envestnet Portfolio Solutions Inc. boosted its stake in shares of LeMaitre Vascular by 10.1% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 3,440 shares of the medical instruments supplier’s stock worth $317,000 after acquiring an additional 315 shares during the period. Finally, CBIZ Investment Advisory Services LLC raised its stake in LeMaitre Vascular by 38.5% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 421 shares of the medical instruments supplier’s stock valued at $39,000 after acquiring an additional 117 shares during the period. Institutional investors and hedge funds own 84.64% of the company’s stock.

Analysts Set New Price Targets

LMAT has been the topic of several research reports. Barrington Research downgraded shares of LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. Wells Fargo & Company assumed coverage on shares of LeMaitre Vascular in a research report on Thursday, February 13th. They set an “equal weight” rating and a $95.00 price objective for the company. Oppenheimer cut LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. Finally, Lake Street Capital upped their price objective on LeMaitre Vascular from $105.00 to $110.00 and gave the company a “buy” rating in a report on Friday, February 28th. Five research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $95.25.

LeMaitre Vascular Price Performance

Shares of NASDAQ LMAT opened at $86.28 on Monday. LeMaitre Vascular, Inc. has a fifty-two week low of $62.40 and a fifty-two week high of $109.58. The stock has a market capitalization of $1.95 billion, a PE ratio of 47.15, a P/E/G ratio of 2.22 and a beta of 0.89. The business has a fifty day moving average price of $87.85 and a two-hundred day moving average price of $93.52.

LeMaitre Vascular (NASDAQ:LMAT) last posted its quarterly earnings data on Thursday, February 27th. The medical instruments supplier reported $0.49 earnings per share for the quarter, hitting the consensus estimate of $0.49. LeMaitre Vascular had a net margin of 19.40% and a return on equity of 13.15%. The business had revenue of $55.81 million during the quarter, compared to analysts’ expectations of $55.99 million. On average, equities analysts expect that LeMaitre Vascular, Inc. will post 1.94 EPS for the current year.

LeMaitre Vascular Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 27th. Investors of record on Thursday, March 13th were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 0.93%. This is a boost from LeMaitre Vascular’s previous quarterly dividend of $0.16. The ex-dividend date of this dividend was Thursday, March 13th. LeMaitre Vascular’s dividend payout ratio (DPR) is 41.24%.

Insider Activity

In related news, insider Trent G. Kamke sold 2,009 shares of the firm’s stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $82.12, for a total value of $164,979.08. Following the sale, the insider now directly owns 5,564 shares of the company’s stock, valued at $456,915.68. This trade represents a 26.53 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 10.79% of the company’s stock.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.